U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. OTP Events, Meetings, and Workshops
  4. Cell Therapies and Tissue-Based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development - 02/25/2025
  1. OTP Events, Meetings, and Workshops

Workshop | Virtual

Event Title
Cell Therapies and Tissue-Based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development
February 25, 2025

Date:
February 25, 2025
Time:
8:30 a.m. - 5:00 p.m. ET

The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on February 25, 2025, titled “Cell Therapies and Tissue-based Products: A Public Workshop on Generating Scientific Evidence to Facilitate Development.” The purpose of the workshop is to identify and discuss the current state of the science, development, and regulation for cellular therapies and tissue-based products.

Meeting Logistics and Registration:

FDA is convening this public workshop with relevant stakeholders to discuss best practices on generating scientific data necessary to further facilitate the development of stem cell and other cellular therapies. Within six months after the meeting, FDA will issue a transcript of the meeting. This workshop will fulfill the requirement under the Food and Drug Omnibus Reform Act of 2022, section 3205. FDA will also publish a notice in the Federal Register and open a docket for public comments. This webpage will be updated once the Federal Register notice is posted.

An agenda will be posted closer to the date of the workshop.

Contact

For questions regarding the public workshop, please contact Claire Simon at Claire.Simon@fda.hhs.gov.

Stay Connected

Sign up for the CBER listserv or follow us on social media to stay up to date on all FDA CBER news and events.

Back to Top